Literature DB >> 7720048

Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation.

M D Lagios1.   

Abstract

Morphologic analysis of nuclear grade and extent of necrosis can provide reproducible classification of subclinical duct carcinoma in situ (DCIS) which strongly separates DCIS into three risk groups. For subclinical lesions of small size, risk is largely limited to local recurrences only, half of which, however, are invasive events. Local recurrences are seen much more frequently with high grade DCIS. Most local recurrences following breast conservation therapy represent residual disease in the immediate vicinity of the biopsy site. Stromal and cellular host reactions may provide additional prognostic information.

Entities:  

Mesh:

Year:  1995        PMID: 7720048     DOI: 10.1016/0304-3835(94)03683-a

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ.

Authors:  L Hayward; R S Oeppen; A V Grima; G T Royle; C M Rubin; R I Cutress
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

2.  Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.

Authors:  Serdar Altinay; Laurent Arnould; Noella Bletard; Cecile Colpaert; Franceska Dedeurwaerdere; Benjamin Dessauvagie; Valérie Duwel; Giuseppe Floris; Stephen Fox; Clara Gerosa; Shabnam Jaffer; Eline Kurpershoek; Magali Lacroix-Triki; Andoni Laka; Kathleen Lambein; Gaëtan Marie MacGrogan; Caterina Marchió; Dolores Martin Martinez; Sharon Nofech-Mozes; Dieter Peeters; Alberto Ravarino; Emily Reisenbichler; Erika Resetkova; Souzan Sanati; Anne-Marie Schelfhout; Vera Schelfhout; Abeer M Shaaban; Renata Sinke; Claudia Maria Stanciu-Pop; Claudia Stobbe; Carolien H M van Deurzen; Koen Van de Vijver; Anne-Sophie Van Rompuy; Stephanie Verschuere; Anne Vincent-Salomon; Hannah Wen; Hélène Dano; Caroline Bouzin; Christine Galant; Mieke R Van Bockstal
Journal:  Mod Pathol       Date:  2019-09-18       Impact factor: 7.842

3.  Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival.

Authors:  Virginia Espina; Brian D Mariani; Rosa I Gallagher; Khoa Tran; Stacey Banks; Joy Wiedemann; Heather Huryk; Claudius Mueller; Luana Adamo; Jianghong Deng; Emanuel F Petricoin; Lucia Pastore; Syed Zaman; Geetha Menezes; James Mize; Jasbir Johal; Kirsten Edmiston; Lance A Liotta
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

4.  Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey.

Authors:  M T van Mackelenbergh; C M Lindner; T Heilmann; I Alkatout; M Elessawy; C Mundhenke; N Maass; C Schem
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-01       Impact factor: 2.915

5.  Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography.

Authors:  Keiko Oshida; Takeshi Nagashima; Takuya Ueda; Hiroshi Yagata; Naoto Tanabe; Shigeharu Nakano; Takashi Nikaidou; Hiroyuki Funatsu; Hideyuki Hashimoto; Masaru Miyazaki
Journal:  Eur Radiol       Date:  2005-03-24       Impact factor: 5.315

6.  There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.

Authors:  H Chauhan; A Abraham; J R A Phillips; J H Pringle; R A Walker; J L Jones
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 7.  What is the malignant nature of human ductal carcinoma in situ?

Authors:  Virginia Espina; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2010-12-02       Impact factor: 60.716

8.  Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.

Authors:  Shinn-Huey S Chou; Eva C Gombos; Sona A Chikarmane; Catherine S Giess; Jagadeesan Jayender
Journal:  J Magn Reson Imaging       Date:  2017-04-03       Impact factor: 4.813

9.  Attacking breast cancer at the preinvasion stage by targeting autophagy.

Authors:  Virginia Espina; John Wysolmerski; Kirsten Edmiston; Lance A Liotta
Journal:  Womens Health (Lond)       Date:  2013-03

10.  Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.

Authors:  P Bethwaite; N Smith; B Delahunt; D Kenwright
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.